Ginkgo Bioworks Holdings, Inc. develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to advance treatments for orphan and rare diseases. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is based in Boston, Massachusetts. The company trades on NYSE exchange. The company headquarter is located in Boston ,United States.

TickerDNA
Long NameGinkgo Bioworks Holdings, Inc.
Short NameGinkgo Bioworks Holdings, Inc.